Main text
(Molecular Therapy 25, 480–493; February 2017)
After investigation, the editors determined the findings to be inconclusive and will not pursue further action at this time.
. 2026 May 6;34(6):3698. doi: 10.1016/j.ymthe.2026.04.058
Knockdown of MicroRNA Let-7a Improves the Functionality of Bone Marrow-Derived Mesenchymal Stem Cells in Immunotherapy
Yang Yu
, Li Liao
, Bingyi Shao
, Xiaoxia Su
, Yi Shuai
, Han Wang
, Fengqing Shang
, Zhifei Zhou
, Deqin Yang
∗∗, Yan Jin
∗
Yang Yu
Find articles by Yang Yu
Li Liao
Find articles by Li Liao
Bingyi Shao
Find articles by Bingyi Shao
Xiaoxia Su
Find articles by Xiaoxia Su
Yi Shuai
Find articles by Yi Shuai
Han Wang
Find articles by Han Wang
Fengqing Shang
Find articles by Fengqing Shang
Zhifei Zhou
Find articles by Zhifei Zhou
Deqin Yang
Find articles by Deqin Yang
Yan Jin
Find articles by Yan Jin
∗
Corresponding author
∗∗
Corresponding author
Issue date 2026 Jun 3.
© 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
PMCID: PMC13239669 PMID: 42895536
This is an expression of concern about the following article: "Knockdown of MicroRNA Let-7a Improves the Functionality of Bone Marrow-Derived Mesenchymal Stem Cells in Immunotherapy" in volume 25 on page 480.